Ventyx Biosciences Inc [VTYX] stock prices are down -2.60% to $2.25 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VTYX shares have gain 19.05% over the last week, with a monthly amount glided 0.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ventyx Biosciences Inc [NASDAQ: VTYX] stock has seen the most recent analyst activity on March 12, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $16 from $7. Previously, Oppenheimer upgraded its rating to Outperform on March 12, 2024, and kept the price target unchanged to $12. On November 07, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $8 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $6 on November 07, 2023. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 07, 2023, and downed its price target to $6. In a note dated November 07, 2023, H.C. Wainwright downgraded an Neutral rating on this stock.
The stock price of Ventyx Biosciences Inc [VTYX] has been fluctuating between $1.67 and $11.48 over the past year. Currently, Wall Street analysts expect the stock to reach $33.86 within the next 12 months. Ventyx Biosciences Inc [NASDAQ: VTYX] shares were valued at $2.25 at the most recent close of the market. An investor can expect a potential return of 1404.89% based on the average VTYX price forecast.
Analyzing the VTYX fundamentals
Gross Profit Margin for this corporation currently stands at -0.05% with Operating Profit Margin at -152.58%, Pretax Profit Margin comes in at -141.75%, and Net Profit Margin reading is -141.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.55 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.19 points at the first support level, and at 2.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.31, and for the 2nd resistance point, it is at 2.36.
Ratios To Look Out For
It’s worth pointing out that Ventyx Biosciences Inc [NASDAQ:VTYX]’s Current Ratio is 23.52. As well, the Quick Ratio is 23.52, while the Cash Ratio is 5.02.
Transactions by insiders
Recent insider trading involved Nuss John, CHIEF SCIENTIFIC OFFICER, that happened on Dec 27 ’24 when 21119.0 shares were sold. Officer, Nuss John completed a deal on Dec 27 ’24 to buy 21119.0 shares. Meanwhile, Director Gujrathi Sheila bought 0.13 million shares on Dec 23 ’24.
